CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CABA — Cabaletta Bio, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in CABA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,165,895
+$1,029,179 QoQ
Shares Held
374,886
+637.6% QoQ
Ownership
0.221%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 139 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CABA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. CABA ranks #218 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in CABA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,165,895 | 374,886 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $136,716 | 50,824 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $111,304 | 50,824 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $118,928 | 50,824 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $76,943 | 50,621 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $221,414 | 159,866 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $248,020 | 109,260 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $593,988 | 125,845 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $885,085 | 118,327 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,595,536 | 93,525 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,186,237 | 96,310 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,461,196 | 96,005 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $884,967 | 68,549 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $83,345 | 10,078 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $93,221 | 10,078 | Shares | Sole | 2023-02-13 | |
| 2021-03-31 | $359,529 | 32,390 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $404,227 | 32,390 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $332,506 | 30,674 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $362,083 | 32,503 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $135,765 | 18,598 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||